Radboud University Medical Center: Coronary Artery Disease trials

The registry lists 15 Coronary Artery Disease studies with Radboud University Medical Center as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 4 4No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Physical Activity Programme Focussed on Step Volume and Intensity for People With Cardiovascular Disease: Getting Active and Staying Active After Cardiac RehabilitationNot yet recruitingNCT07723274Not applicable
• Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)Enrolling by invitationNCT07625488
• South East (Zuid Oost) Netherlands Heart RegistryRecruitingNCT06512493
• The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)Enrolling by invitationNCT06083155
• TREAT Study - Improving the Interpretation of Troponin Concentrations Following Exercise and Their Clinical SignificanceActive, not recruitingNCT06295081
• Remote 3-week Booster Intervention to Reduce Sedentary Time in Patients With Coronary Artey DiseaseCompletedNCT06038188Not applicable
• Trained Immunity by Dual-pathway Inhibition in Coronary Artery DiseaseStatus unknownNCT05210725Phase 4
• Neuroinflammation in Cognitive Decline Post-cardiac SurgeryCompletedNCT04520802
• Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 AntibodyCompletedNCT04141579Not applicable
• The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart SurgeryStatus unknownNCT03939273Not applicable
• Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting LesionsActive, not recruitingNCT03857971Not applicable
• Epigenetic Reprogramming of Monocytes in Patients With Coronary AtherosclerosisCompletedNCT02393768
• The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) TrialCompletedNCT01438723Phase 4
• Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?CompletedNCT01295567Phase 4
• Persantin Preceding Elective PCICompletedNCT00767663Phase 4